MTS Atlas
Built with+
SituationsCompaniesModelsInvestors
← All investors
BS

Firm & fund profile / Sourced portfolio

Bristol-Myers Squibb

Tracked participation in 1 Atlas company, with 1 explicitly attributed lead.

1portfolio companies
2round participations
1lead positions
$80Mled round total
Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jun 2022OwkinStrategic collaboration with Bristol Myers Squibb (incl. Series B-1 equity investment)$80M
Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleLatest round
OOwkin logoOwkin—Jun 2022 → Invalid Date2 rounds1 ledTotal disclosed (company press kit aggregate)